
Issue 12, Spring 2021
General OrthoForum Policy Issues
Medicare Sequestration Cut Suspension Extended
The suspension of the Medicare sequestration cut has been extended through December 31, 2021 (and the cut will now take effect on January 1, 2022).
Under the Budget Control Act of 2011, a 2 percent across-the-board cut in Medicare provider payments applies, but the CARES Act (enacted March 27, 2020) suspended that cut from May 1, 2020, through December 31, 2020. Then the Consolidated Appropriations Act, 2021, (enacted on December 27, 2020) extended the suspension through March 31, 2021.
The House passed legislation on March 19, 2021, to further extend the suspension (H.R. 1868). The Senate considered the House bill on March 25, but modified it, which sent the bill back to the House. The House did not consider the Senate version until April 13; therefore, the extension expired on April 1. CMS, however, announced it would stop processing Medicare claims to give Congress time to complete action. On April 13, the House accepted the Senate version of the bill, which sent the bill to the President’s desk. President Biden signed the bill on April 14 and it became Public Law 117-7. This new law extended the suspension through December 31, 2021.
Balance Billing Update
First Regulations Due by July 1
As previously reported, HHS will be leading the implementation of the No Surprises Act (the balance billing ban enacted in December 2020), which will take effect on January 1, 2022. As the first regulations deadline of July 1 approaches, however, some of the key HHS officials and staff who will need to make important decisions about those regulations have yet to be appointed or confirmed. Even so, HHS has been holding calls with industry groups to collect feedback in recent months, although those calls have mostly focused on technical details versus payment issues and enforcement of the ban.
Moreover, given the tight timeframe, there is an issue of whether HHS will follow the normal rulemaking process of issuing a proposed rule, followed by a period for comments from the public and then a final rule that addresses those comments.
An HHS spokesperson recently stated it was too early to “speculate on the final rulemaking process”, and explained that the feedback from the calls with industry groups would “offer solid footing for rulemaking built on best practices, transparency and the needs of all Americans.”

HHS Secretary Xavier Becerra recently assured House appropriators he would seek input from stakeholders before implementing a balance billing fix, but he did not explicitly say HHS would use the normal rulemaking process in implementing the law. In addition, Chiquita Brooks-LaSure—President Biden’s nominee to be the CMS Administrator—testified before the Senate Finance Committee on April 15 and told lawmakers that, if confirmed, she would work hard to get regulations out on the No Surprises Act as soon as possible, noting the tight timeline.
The July 1 deadline is for regulations to provide details on the methodology that health plans will use to determine the “qualifying payment amount”, which (for the item or service involved) is the median in-network contracted rate in the geographic area involved for the applicable insurance market (large group market, small group market, or individual market) as adjusted for inflation occurring after January 31, 2019. The qualifying payment amount is one of the factors considered in the process for an independent dispute resolution (IDR). It is also part of the methodology for determining the amount of the patient’s cost-sharing payment.
The qualifying payment amount is used for IDR purposes and patient cost-sharing purposes unless there is a State law that governs the amount of payments to out-of-network providers, or unless the State is participating in the CMMI All-Payer Model. If there is such a State law, or if the State is participating in that Model, the IDR process is not available.
Prior Authorization

In the 2021 final rule concerning ASCs that was published on December 29, 2020, CMS stated that “we have structured the Medicare Fee-For-Service prior authorization processes to effectively account for concerns associated with processing timeframes, patient care, and other administrative concerns.”
Presumably, this means that no changes to the prior authorization requirements of CMS will be made unless Congress takes action. Thus far in 2021, no bills have been introduced that would affect the agency’s prior authorization requirements in Medicare. One bill has been introduced that would require CMS to annually notify Medicare beneficiaries of prior authorization requirements and also other utilization management techniques. This is H.R. 2410, a bipartisan bill from Representatives Mike Kelly (R-PA) and Tom O’Halleran (D-AZ). Kelly is on the Ways & Means Committee and O’Halleran is on the Energy & Commerce Committee.
Additional Information
For more information on any of the topics discussed in this section, please contact the chair of the OrthoForum Advocacy Committee, Dr. Richard Bruch, at rich.bruch@gmail.com.
Therapy Services Update
Medicare Reimbursement
The Advocacy Committee continues to be concerned about the cuts to Medicare reimbursement under the Physician Fee Schedule (PFS) for physical therapists (PTs) and occupational therapists (OTs) and their assistants. The 2021 PFS cut, the PFS cut expected for 2022, and the sequestration cut scheduled for 2022 will have negative effects on therapy services. The Committee is developing a strategy to respond to this issue.


Medicare Telehealth Issues
In the 117th Congress (which began in January), the Advocacy Committee remains focused on changing Medicare’s statutory telehealth provisions in order to establish permanent authority for PTs and OTs and their assistants to be telehealth providers. As noted in our previous newsletters, the type of permanent authority we seek would not rely on the existence of a federally-declared national public health emergency (PHE) or a CMS waiver. The Committee supports the enactment of legislation that would permanently authorize PTs, OTs, and their assistants to be telehealth providers; would eliminate telehealth geographic limitations; and would eliminate restrictions on the site at which the patient receives telehealth services, including allowing the patient’s home to be a site of service. As discussed in more detail below, the House has had two hearings on telehealth issues, and several bills of interest have been introduced in this Congress.
House Telehealth Hearings
On March 2, the health subcommittee of the House Energy and Commerce Committee held a hearing titled, “The Future of Telehealth: How COVID-19 Is Changing the Delivery of Virtual Care.” Testimony from public health experts and health care executives discussed the effectiveness of telehealth services during the COVID-19 pandemic and the implications of telehealth for the future of medicine. Members on both sides of the aisle praised the expanded telehealth policies during the pandemic and there was broad consensus that some telehealth services should be made permanent. Members, however, expressed concern that the ease of using telehealth services could lead to an increase in fraud, overutilization, and abuse. Witnesses countered that point of view, noting that the little existing research on utilization and cost-effectiveness of telehealth services indicates patients are no more likely to overuse telehealth than traditional healthcare services.
On April 28, the health subcommittee of the House Ways and Means Committee held a hearing titled, “Charting the Path Forward for Telehealth.” During the hearing, lawmakers and witnesses explored issues related to expanding telehealth services and ensuring telehealth does not exacerbate or lead to new inequities, among other issues. Chair Lloyd Doggett (D-TX) applauded the work of CMS in allowing waivers to cover 144 telehealth services during the pandemic. He warned members, however, to be cautious about supporting a two-tiered telehealth system, with those in rural areas not having the same access as others. Chair Doggett said he intends to hold a markup on telehealth legislation and announced he would be introducing a bill to extend the telehealth waivers after the conclusion of the COVID-19 PHE. He asked for advice on what Congress should know before moving forward with telehealth legislation, and Ateev Mehrotra, a Harvard Associate Professor of Health Care Policy, noted the importance of understanding the impact of telemedicine on total utilization since usage rates during the pandemic may have skewed the data. Rep. Mike Thompson (D-CA) said Congress must do three things: maintain the stability of the Medicare Trust Fund, expand telehealth equally, and monitor quality of care.

In the Senate:
- The Telehealth Modernization Act (S. 368), a bipartisan bill introduced on February 23 by Senators Tim Scott (R-SC) and Brian Schatz (D-HI) that has 7 cosponsors, including several senators who are sponsors of the separate CONNECT Act (such as Schatz, the lead sponsor of that Act). S. 368 would authorize (but not require) CMS to expand the list of telehealth providers to include any health care professional who is eligible to bill Medicare. This presumably would include PTs and OTs once a physician has certified the plan of care, but it would not include their assistants. The bill would eliminate telehealth geographic limitations, as well as restrictions on the site at which the patient may receive telehealth services, including allowing the patient’s home to be a site of service. In addition, CMS would have the authority to keep in place the telehealth waivers it has issued for the COVID-19 PHE even after the PHE is over. This authority could serve as a transition period as CMS considers whether and how to expand the list of telehealth providers.
- The CONNECT for Health Act of 2021 (S. 1512), a bipartisan bill introduced on April 29 by Senators Brian Schatz (D-HI) and Roger Wicker (R-MS) that has 49 cosponsors, including Tim Scott (R-SC) (the lead sponsor of S. 368, discussed above). S. 1512 would authorize (but not require) CMS to expand the list of telehealth “practitioners,” to eliminate telehealth geographic limitations, and to eliminate restrictions on the site at which the patient receives telehealth services, including allowing the patient’s home to be a site of service. The definition in current law of “practitioner” would not be changed or supplemented, however; therefore, PTs and OTs could not become telehealth providers under the bill. The bill would authorize (but not require) CMMI to create a demonstration model to test expanding the types of health professionals who can provide telehealth services, and CMMI would have authority for the model to include PTs, OTs, and their assistants.
In the House:
- The Telehealth Modernization Act (H.R. 1332), a bipartisan bill introduced on February 25 by Representatives Buddy Carter (R-GA) and Lisa Blunt Rochester (D-DE) that has 28 cosponsors. This bipartisan bill is a companion to S. 368 (discussed above).
- The Expanded Telehealth Access Act (H.R. 2168), a bipartisan bill introduced on March 23 by Representatives Mikie Sherrill (D-NJ) and David McKinley (R-WV) that has 26 cosponsors. This bipartisan bill would upon enactment (without CMS having to take any action) permanently authorize PTs, OTs, their assistants, and certain other health professionals to be telehealth providers. The bill, however, does not include any provisions to eliminate the telehealth geographic limitations or to eliminate restrictions on the site at which the patient receives telehealth services.
- The CONNECT for Health Act of 2021 (H.R. 2903), a bipartisan bill introduced on April 28 by Representatives Mike Thompson (D-CA) and David Schweikert (R-AZ) that has 4 cosponsors. This bipartisan bill is a companion to S. 1512 (discussed above).
Therapy Services Subcommittee
For more information on therapy services issues, or to join the OrthoForum Advocacy Committee Therapy Services Subcommittee, please contact Renee Duncan at: renee.duncan@orthotennessee.com.
CMS/CMMI Update
Extension of CJR Model
On April 29, the Centers for Medicare & Medicaid Services (CMS) released a final rule to extend and modify the CJR Model. The final rule is scheduled to be published in the Federal Register on May 3. The extension does not apply to hospitals in metropolitan statistical areas (MSAs) for which participation is voluntary, or to rural hospitals or low-volume hospitals (even those in mandatory MSAs). The final rule includes the following summary:
This final rule extends the length of the Comprehensive Care for Joint Replacement (CJR) model through December 31, 2024 by adding an additional 3 performance years (PYs). PY 6 will begin on October 1, 2021 and end on December 31, 2022; PY 7 will begin on January 1, 2023 and end on December 31, 2023; and PY 8 will begin on January 1, 2024 and end on December 31, 2024. In addition, this final rule revises certain aspects of the CJR model including the episode of care definition, the target price calculation, the reconciliation process, the beneficiary notice requirements, and the appeals process. In addition, for PY 6 through 8, this final rule eliminates the 50 percent cap on gainsharing payments, distribution payments, and downstream distribution payments for certain recipients. This final rule extends the additional flexibilities provided to participant hospitals related to certain Medicare program rules consistent with the revised episode of care definition.
CMS also states that “the extension of the CJR model would only apply to participant hospitals located in the 34 mandatory metropolitan statistical areas (MSAs) for whom participation has been mandatory since the beginning of the model in 2016. This proposal excludes rural and low-volume hospitals in the 34 mandatory MSAs and any voluntary hospitals in 33 voluntary MSAs that have opted into the model for PYs 3 through 5. The model currently enrolls 139 voluntary, rural, and low-volume hospitals. Excluding rural, low-volume, and voluntary hospitals from the model results in 330 hospitals in the 34 mandatory MSAs participating in PYs 6 to 8.”

Senate Confirmation Process for Nominee for CMS Administrator
As we forecasted last quarter, the Biden administration nominated Chiquita Brooks-LaSure to serve as the next administrator of CMS. Brooks-LaSure sailed through her nomination hearing, but on April 22, the Senate Finance Committee deadlocked on advancing her nomination in a 14-14 party-line vote. Republican opposition towards what previously appeared to be a smooth confirmation process for Brooks-LaSure spiked following the announcement that CMS would rescind a Trump-era extension for Texas’ Medicaid section 1115 waiver. The waiver provided funding for uncompensated care in the absence of an expanded Medicaid program, and was approved by then-CMS Administrator Seema Verma in the final days of the Trump administration. The waiver is now set to expire October 2022.
Sen. John Cornyn (R-TX) indicated he would put up a procedural roadblock to the nomination, accusing the Biden administration of playing “political chicken” by rescinding the waiver in a bid to pressure Texas and the remaining state-holdouts to expand Medicaid under the Affordable Care Act (ACA). Cornyn’s procedural roadblock only has the ability to slow the nomination, not stop it, as the hold effectively requests a temporary block to prevent the vote from coming to the floor which Senate Majority Leader Chuck Schumer (D-NY) may choose to grant or deny. Additionally, the tie vote on the CMS nominee will force Majority Leader Schumer to file a discharge petition in order to bring Brooks-LaSure’s nomination for a vote before the entire Senate.
Brooks-LaSure will likely be confirmed in the coming weeks, since she is expected to have support from every Democratic senator. Upon confirmation, she would bring over 20 years of experience in health policy to CMS, most recently serving as Managing Director at Manatt Health. She previously worked with CMS as Deputy Director for Policy within the Center for Consumer Information and Insurance Oversight, and led implementation of ACA coverage and insurance reform policy provisions as director of coverage policy at HHS. She has also worked as a Democratic staffer for the House Ways and Means Committee, and was previously the lead Medicaid analyst for the Office of Management and Budget, coordinating Medicaid policy development for the health financing branch.
Brooks-LaSure has criticized Medicaid work requirements and excessive Medicaid eligibility redeterminations as barriers to coverage, advocating for a federal coverage guarantee to protect beneficiaries from potential coverage rollbacks in states that have expanded Medicaid.

Overall Direction of CMMI
On March 1, Elizabeth Fowler began serving as director at the Center for Medicare and Medicaid Innovation (CMMI). She formerly worked in the Senate as the chief health counsel for the Finance Committee, where she played a crucial role in drafting the ACA. Fowler later helped implement the ACA at the Department of Health and Human Services (HHS), where she held various positions before joining Johnson & Johnson as Vice President for Global Health Policy. She also spent time on the National Economic Council, specializing in health care and economic policy under the Obama administration.
As head of CMMI, Fowler will build upon the goals of the ACA, guiding the agency as a key architect of the law. In January 2021, Fowler co-authored an article with her Commonwealth Fund colleagues, detailing their predictions for health care under the Biden administration within the context of the COVID-19 pandemic. The article anticipates increased federal funding for states facing heightened demands for health services with lower-than-expected revenues, effectively preserving widespread Medicaid coverage gains made over the last decade. Notably, Fowler and her colleagues state the pandemic will “accelerate provider interest in payment models that encourage value-based care, in part because such models also protect against losses in the event of dramatic declines in volume like those experienced during the pandemic.” The article continues that the path towards value and new payment models will require continued efforts from policymakers, investment by provider systems, and rigorous evaluation. These comments reflect the broader expectation that CMMI will focus on furthering value-based care, centering reimbursement on outcomes rather than volume.
Fowler confirmed this during a National Association of ACOs spring conference in late April, where she indicated the center will look to expand its multi-payer partnerships, focus on health equity and work on White House priorities, including drug pricing. She further clarified that the center’s commitment to value-based care has never been stronger, stating that CMMI wants models to position participants for success with value-based care. She noted that only a handful of models have been certified to be a permanent part of Medicare and wondered instead whether the center could look at the overall goal as transformation of the health care system, or both broader system transformation along with certification, so that evaluation isn’t what drives model design or development. She also indicated that stakeholders should expect CMMI to focus on advancing health equity as it will be included in each of the innovation center’s models.

On April 27, CMS released the 2022 IPPS proposed rule, which is scheduled to be published in the Federal Register on May 10. Among other provisions, the proposed rule:
- Provides an increase of approximately 2.8 percent to hospitals paid under the IPPS. To get this increase, hospitals must successfully participate in the Hospital Inpatient Quality Reporting Program and be meaningful electronic health record users.
- Eliminates the requirement that a hospital report on the Medicare median payer-specific negotiated charge that the hospital has negotiated with all of its Medicare Advantage payers for cost reporting periods ending on or after January 1, 2021. CMS said it estimates this will reduce the administrative burden on hospitals by approximately 64,000 hours.
- Requires hospitals to report COVID-19 vaccination rates among their workers.
- Extends the add-on payment for new COVID-19 treatments through the end of the year in which the current public health emergency ends.
- Shores up the medical workforce in rural and underserved communities.
- Distributes 1,000 new Medicare-funded medical residency positions to qualifying hospitals, phasing in 200 slots per year over five years.
- Upholds the administration’s focus on equity, soliciting stakeholder feedback on ways to improve health equity.
CMS/CMMI Subcommittee
For more information on CMS, CMMI, and BPCI-A issues, or to join the OrthoForum Advocacy Committee CMS/CMMI Subcommittee, please contact the chair of the Subcommittee, Dr. Doug Lundy, at LundyDW@resurgens.com.
Stark Law Update

Group Practice Provisions of Stark Law Final Rule
The federal Stark Law concerns referrals and profits related to “designated health services” (DHS), such as clinical lab services, diagnostic imaging, and physical and occupational therapy services. It does not apply to clinic activities such as evaluation and management (EM) visits and performing orthopedic procedures. (State laws governing referrals and profits may be broader than the Stark Law.)
The Stark final rule published in December 2020 has two basic categories of changes—those that apply within the context of a “value-based arrangement” (VBA) and those that apply regardless of whether there is a VBA (i.e., changes to long-standing Stark regulations that do not concern VBAs).
Although the Advocacy Committee continues to study the VBA provisions of the Stark final rule, our primary focus over the last several months has been on changes made by the final rule to the regulations governing how group practices divide overall profits. These changes will take effect on January 1, 2022.
On April 15, the Committee had a video presentation for OrthoForum members in order to provide an introduction to these group-practice changes. Pursuant to discussions of the Committee that took place after that presentation, the Committee has submitted questions to the Centers for Medicare & Medicaid Services (CMS) to seek clarification on several issues, and we are waiting for the agency’s responses.
After consideration of the new regulations, and also the preamble to the final rule (the explanation of CMS on its changes to the regulations), there are several takeaways:
- It is a violation of the group-practice regulations to have an overall-profits distribution formula under which compensation goes up or down on the basis of the volume or value of referrals.
- It is a violation to make “service-by-service” distributions of overall profits, such as having one division of physicians receive clinical-lab profits and a different division receive diagnostic-imaging profits.
- Otherwise, it appears that approaches used in the past will continue to be acceptable.
Any distribution method made in “a reasonable and verifiable manner” is allowed. Divisions (referred to in the regulations as “components”) of at least five physicians can be created on the basis of similar practice patterns; practicing in the same location; similar years of experience; similar tenure with the group practice; or other criteria determined by the group practice. The profits of a division can be pooled and distributed within the division. Each division can use a different distribution formula; however, the formula for a division must apply to everyone in the division.
As to value-based arrangements, there is a new provision on this in the group practice regulations, which will take effect on January 1, 2022. The Advocacy Committee intends to have a video presentation on VBAs in June.
Stark Law Subcommittee
For more information on Stark Law issues, or to join the OrthoForum Advocacy Committee Stark Law Subcommittee, please contact the chair of the Subcommittee, Dr. Chip Hummer, at chummer3@premierortho.com.
Ambulatory Surgery Center Update

Generally
The OrthoForum will hold the annual ASC conference on August 12 through 14 in Charlotte, North Carolina. Details will be provided soon. Members are encouraged to attend.
The Advocacy Committee continues to focus on the Medicare budget-neutrality issue and the site-neutrality issue, as well as the issue of generating quality data and cost data. These issues are discussed below. Our efforts include coordinating as appropriate with other organizations, such as the Ambulatory Surgery Center Association (ASCA).
Medicare Budget Neutrality
As noted in previous newsletters, CMS takes the position that the Medicare ASC payment system must be budget neutral, meaning that the amount of the money in the system must stay the same from year to year except for increases resulting from updates to the ASC conversion factor. Therefore, any increase in payment for one procedure must be offset by a reduction in payment for one or more other procedures. This CMS position (also referred to as the ASC weight scaler) has always been a problem, but the Advocacy Committee expects it to get worse due to the elimination of the inpatient-only (IPO) list.
The removal of a procedure from the IPO list automatically makes the procedure allowable in hospital outpatient departments (HOPDs), which in turn allows the procedure to be considered by CMS for possible addition to the ASC Covered Procedures List (CPL). The addition over time of procedures to the ASC will lower reimbursement rates for procedures that were on the CPL prior to 2021, as the budget-neutrality requirement means that the finite amount of funds for the ASC payment system (increased only by the annual update to the ASC conversion factor) will be allocated among more and more procedures.
The Advocacy Committee is developing a strategy to educate Congress about the issue and the threat it poses to maintaining a sustainable ASC system.
In the 2021 final rule concerning ASCs, CMS acknowledged the problem, apparently referring to a statement in the OrthoForum comment letter on the proposed rule. The agency stated, “One commenter . . . suggested the while expansion of the ASC Covered Procedures List would allow more procedures to be performed in the ASC, these additional procedures will not be performed in the ASC if ASC payment rates are lowered to unsustainable levels over time.”
Site Neutral Payments
Medicare reimburses ASCs at a rate that is about 59 percent of the rate for HOPDs. Letters sent to CMS by the Advocacy Committee have noted our support for site neutrality between ASC payments and HOPD payments. It appears that CMS generally supports the principle that the payment for a procedure should be the same regardless of the location at which the procedure is performed. The agency’s position on ASC budget neutrality, however, suggests that it may take action by Congress to achieve ASC-HOPD site neutrality. The Advocacy Committee is developing a strategy to educate Congress on this issue.

Quality and Cost Data
The Advocacy Committee believes that ASCs should expand efforts to collect data demonstrating the quality of procedures performed in ASCs, including aggregating the data. This will help respond to any negative articles by media reporters. It will also be helpful with the Medicare Payment Advisory Commission (MedPAC), many of whose members apparently do not have a favorable attitude toward ASCs. And quality data will help with efforts of the Advocacy Committee directed to Congress. For example, we likely will be approaching Congress on the use of the hospital market basket to update the ASC conversion factor. Currently, CMS has only committed to using the market basket through 2023.
Cost data is also important to our efforts to increase ASC payments. ASCs should work to together to put together a workable, streamlined approach to collect such data. MedPAC consistently recommends against any updates to the ASC conversion factor because of the lack of cost data.
Developing a workable, streamlined system to collect cost data is also important to avoid having CMS or Congress impose the same system that is used for hospitals. In the 2021 final rule concerning ASCs, CMS stated that it “will continue to assess the feasibility of collaborating with stakeholders to collect ASC cost data in a minimally burdensome manner”. The agency continued that it potentially could “propose a plan to collect such information during the 5-year period in which CMS has updated the ASC payment methodology to rely upon the hospital market basket as the update factor”. The Advocacy Committee plans to work with CMS and MedPAC to develop an ASC cost reporting methodology.
ASC Subcommittee
For more information on ASC issues, or to join the OrthoForum Advocacy Committee ASC Subcommittee, please contact Teresa Copeland at: teresa.copeland@orthotennessee.com.
Physician-Owned Hospital (POH) Update

Representative Michael Burgess (R-TX), a physician and a high-ranking member of the House Energy & Commerce Committee, introduced a bill on February 25 to repeal the Stark Law restrictions on physician-owned hospitals (POHs) that were enacted in 2010 as part of the Affordable Care Act (H.R. 1330). The lead cosponsor is Representative Vicente Gonzalez (D-TX). The bill has 24 cosponsors, of which three are Democrats. There is no companion bill in the Senate.
It is unlikely that H.R. 1330 will be seriously considered because many in Congress, particularly senior Democrats, oppose the bill. Apparently, this is because they continue to believe that POHs avoid low-income patients and sicker patients (i.e., cherry pick). They also may fail to take into consideration that POHs can be part of the answer to addressing the negative effects of hospital consolidation. A reasonable request to federal policymakers would be to ask for an explanation of why it is considered permissible for private-equity firms to own entire multi-state hospital systems but not for physicians to own individual hospitals.
The question is whether Congress can be persuaded to modify its views. It may be that the best way to educate Congress is through informing it about the results of studies by researchers with respected credentials.
Examples of studies:
Published in the British Medical Journal, September 2015. Conducted by researchers from Harvard, University of California, and Massachusetts General Hospital.
Conclusion: “Using a comprehensive list of POHs across the United States and contemporary data, we found no evidence that POHs systematically avoid poorer patients or those from ethnic and racial minority groups. POHs also performed equally to non-POHs on a wide array of measures of quality of care, costs, and payments for care. These findings indicate a need to re-examine existing public policies that target all hospitals with physician owners.” (Emphasis added.)
Published in Health Affairs, April 2021. Analysis by board members of the AMA, AAOS, and the American College of Cardiology.
Conclusion: “A problem acknowledged by both Democrats and Republicans, hospital consolidation, regardless of its causes, presents a vexing stumbling block to better care for Americans . . . With a pandemic underscoring the need for flexible, dynamic hospital capacity, now is the time for congressional correction of Section 6001, a provision contrary to the ACA’s goals of expanding access to care, improving quality, and promoting innovation.” (Emphasis added.)
Published in Health Affairs, May 2021. Conducted by researchers from the Rand Corporation, Boston University, and Baylor University.
Conclusion: “In recent years direct ownership of physician practices by hospitals and health systems (that is, vertical integration) has become a prominent feature of the US health care system . . . This study highlights how the growing trend of vertical integration, combined with differences in Medicare payment between hospitals and nonhospital providers, leads to higher Medicare spending . . . We found that during the 2013–16 period, vertical integration between physician group practices and hospitals or health systems was associated with increases both in hospital sites of care for common diagnostic imaging and laboratory tests and in Medicare reimbursement rates . . . Hospitals and health systems have a strong financial interest in capturing the referral patterns of physicians, especially those they employ. These incentives and downstream outcomes can sometimes be at odds with patients’ best interests, however.” (Emphasis added.)
Published in Health Affairs, May 2021. Conducted by researchers from Northeastern University, Boston University, and Stonehill College.
Conclusion: “The transition among many US physicians from independent practice to hospital employment has raised concerns about whether employed physicians will be more inclined to refer patients for hospital-based services that are unnecessary or inappropriate . . . Study findings indicate that the odds of a patient receiving an inappropriate MRI referral increased by more than 20 percent after a physician transitioned to hospital employment. Most patients who received an MRI referral by an employed physician obtained the procedure at the hospital where the referring physician was employed. These results point to hospital-physician integration as a potential driver of low-value care.” (Emphasis added.)
Published in Health Affairs, August 2020. Conducted by researchers from the HHS Agency for Healthcare Research and Quality (AHRQ) and from Mathematica. Study funded by AHRQ.
Conclusion: “Provider consolidation into vertically integrated health systems increased from 2016 to 2018. More than half of US physicians and 72 percent of hospitals were affiliated with one of 637 health systems in 2018. For-profit and church-operated systems had the largest increases in system size, driven in part by a large number of system mergers and acquisitions . . . Provider consolidation into integrated systems may lead to highly concentrated markets along both horizontal and vertical dimensions. Future research should examine the drivers of consolidation and variation in performance by ownership type; geographic variation in the extent of health system penetration across local health care markets; and the ramifications of increased consolidation on cost, access, and quality of care.” (Emphasis added.)
Published in the New England Journal of Medicine, January 2020. Conducted by researchers from Harvard, Beth Israel Deaconess Medical Center, and Brigham and Women’s Hospital. Study funded by AHRQ.
Conclusion: “Hospital mergers and acquisitions were associated with modest deterioration in patient experiences, small and nonsignificant changes in readmission and mortality rates, and inconclusive effects on performance on clinical-process measures. These findings challenge arguments that hospital consolidation, which is known to increase prices, also improves quality.” (Emphasis added.)
Analysis by the nonprofit Health Care Cost Institute, 2021.
Conclusion: “One frequently cited factor for the continued rise in health care prices is that health care provider markets have become increasingly concentrated over time, and therefore less competitive . . . While metro areas varied in their levels of concentration, by 2017, the majority of metros would be categorized as highly concentrated markets. This reflects the fact that most metros became increasingly concentrated over time . . . A common way to measure concentration within a market is to calculate a Herfindahl-Hirschman Index (HHI) . . . In 2017, 87 metros of the 124 studied (70%) had hospital markets with HHI values that could qualify as a highly concentrated per the Department of Justice (DOJ).” (Emphasis added.)
Published by the Robert Wood Johnson Foundation, June 2012. Conducted by researchers from Carnegie Mellon University and the Wharton School, University of Pennsylvania.
Conclusion: “Hospital consolidation generally results in higher prices. This is true across geographic markets and different data sources. When hospitals merge in already concentrated markets, the price increase can be dramatic, often exceeding 20 percent. Hospital competition improves quality of care. This is true under both administered price systems, such as Medicare and the English National Health Service, and market determined pricing such as the private health insurance market. The evidence is more mixed from studies of market determined systems, however. Physician-hospital consolidation has not led to either improved quality or reduced costs. Studies find that consolidation was primarily for the purpose of enhanced bargaining power with payers, and hence did not lead to true integration. Consolidation without integration does not lead to enhanced performance.” (Emphasis added.)
Physician-Owned Hospital Subcommittee
For more information on POH issues, or to join the OrthoForum Advocacy Committee POH Subcommittee, please contact the chair of the Subcommittee, Dr. Blake Curd, at bcurd@oi.md.
Political Update

As a rule, the few months after a presidential election are quiet in terms of political news, but every 10 years that rule is suspended.
The 2020 US Census will generate small but potentially decisive changes in the political picture for 2022. Per the Census results released late in April, congressional reapportionment will add three House seats to states that voted for Donald J. Trump for president in 2020, and subtract three House seats from states that awarded their electoral votes to Joe Biden.
A shift of three seats may sound inconsequential, but Democrats’ currently hold an edge of just seven seats. And reapportionment is just part one of the decennial changes to House seats. The second part, which is likely to be more consequential, is redistricting.
Reapportionment shifts seats between states to reflect population changes; redistricting redraws districts within states. Reapportionment is a nonpartisan mathematical process; redistricting is conducted by politicians (or in some states, by nonpartisan commissions). Redistricting offers the opportunity to change or preserve the partisan composition of state congressional delegations.
Republicans are in a much more favorable position than Democrats as the redistricting process begins. Republicans have complete control—legislature plus governorship (in states in which the governor participates)—in enough states to give them a combined total of 188 seats in the House; Democrats have complete control in enough states to give them a combined total of just 73 seats in the House.
Thus, the three-seat change wrought by the 2020 Census is best understood in the context of larger changes. Some House election analysts have asserted that without any change in the political environment, and with the same voter turnout as in 2020, Republicans will win the House in 2022 strictly because of changes made in the reapportionment and redistricting processes.
Republicans are also buoyed by the historical fact, well-known to Washington DC’s political junkies, that the president’s party has experienced a net loss of House seats in 37 of 39 midterm elections(!).
That doesn’t mean that we can predict the result of the 2022 House races this far from Election Day –there are plenty of variables still to be established. But this does provide the framework through which policymakers, advocacy groups, and the media are looking at the 2022 election cycle.
Senate cycles are less predictable than their House counterparts. Since only one-third of the Senate is up for re-election in any given cycle, the roster of races is of great importance. In the 2018 cycle, President Donald Trump’s midterm, Republicans lost 41 House seats but gained two Senate seats. Republicans flipped Democratic seats in Florida, Indiana, Missouri, and North Dakota; Democrats won GOP seats in Arizona and Nevada. As you can see, states’ Senate preferences increasingly align with their presidential preferences.
In the Senate, the 2022 picture is slightly worse for Republicans, and slightly better for Democrats. Republicans are defending 20 seats, and Democrats are defending 14. Perhaps more important, Republicans are defending five open seats, Democrats none. With Republicans defending open seats in North Carolina, Ohio, Pennsylvania and Wisconsin, and Democrat incumbents defending seats in Arizona, Georgia, Nevada and New Hampshire, the battle for control of the Senate is considered by forecasters to be a toss-up.

Political experts will consider the quality of Senate nominees, President Joe Biden’s favorability ratings, the state of the economy, and other factors in making predictions closer to Election Day 2022. In the meantime, you now have the background you need to view the 2022 races like an expert.
With respect to the quality of nominees, the 2020 cycle provides a vivid illustration. Republicans’ substantial gains in the House were highlighted by the election of 15 female Republican candidates, a record for the party. In all, 227 Republican women ran for House seats (this figure includes primary candidates), also a record. The party made a concerted effort to find more female candidates, and reaped the rewards on Election Day.


































































